| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
chiachen_cheng [2022/05/02 04:01] liam | chiachen_cheng [2022/05/02 06:17] (current) liam [Awards and funding] |
|---|
| ===== Education ===== | ===== Education ===== |
| |
| Cheng completed her General Psychiatry residency and Child & Adolescent Psychiatry sub-specialization at [[McMaster University]]. | Cheng graduated from [[Queen's University]] in 1997.((//Cheng, Chiachen - Doctor Details.// College of Physicians and Surgeons of Ontario. Retrieved May 1, 2022, from https://web.archive.org/web/20220502020333/https://doctors.cpso.on.ca/DoctorDetails/Cheng-Chiachen/0138928-71164)) |
| | |
| | She completed her General Psychiatry residency and Child & Adolescent Psychiatry sub-specialization at [[McMaster University]].((//Community Partners.// Lakehead University. Retrieved May 1, 2022, from https://www.lakeheadu.ca/centre/cranhr/people/partners)) She received a Masters of [[Public Health]] from [[Harvard University]].((//Annual Retreat 2011 Biographical Notes.// (2011). Ontario Psychiatric Outreach Program. https://web.archive.org/web/20220502022039/https://www.porticonetwork.ca/documents/366159/1073224/2011+retreat+presenter+bios.pdf/d09b46d7-9d01-486a-8033-e287d7ffced7)) |
| | |
| | She subsequently received a two-year postdoctoral fellowship through the [[Canadian Institutes of Health Research]]’s Research in Addictions and Mental Health Policy and Services program. |
| |
| ===== Career and Affiliations ===== | ===== Career and Affiliations ===== |
| |
| | ==== Ontario Psychiatric Association ==== |
| | |
| | Cheng was a member of the executive council of the [[Ontario Psychiatric Association]] in 2005.((//Dialogue.// (2005, June). Ontario Psychiatric Association. https://web.archive.org/web/20220502040248/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_June2005.pdf)) ((//Dialogue.// (2005, March). Ontario Psychiatric Association. https://web.archive.org/web/20220502040455/https://www.eopa.ca/sites/default/uploads/files/DialogueNL_Mar2005.pdf)) |
| | |
| | At the time, sponsors for the OPA included [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Biovail]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Genpharm]], [[pharmaceutical_companies:Lundbeckl]], [[pharmaceutical_companies:Organon]], [[pharmaceutical_companies:Shire]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:Wyeth]] (a [[pharmaceutical_companies:Pfizer]] company). |
| ==== Northern Ontario School of Medicine ==== | ==== Northern Ontario School of Medicine ==== |
| |
| |
| Her salary at St. Joseph's was $220,245.42 in 2019 and $252,330.60 in 2021.((//Public Salary Disclosure - St. Joseph’s Care Group - 2019.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20210325162058/https://www.sjcg.net/documents/accountability/salary-executive-contracts/salary/2019_Public-Sector-Salary-Disclosure_Bilingual.pdf)) ((//Public Salary Disclosure - St. Joseph’s Care Group 2021.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20220502014258/https://sjcg.net/documents/accountability/salary-executive-contracts/salary/2021_Public_Sector_Salary_Disclosure_Bilingual.pdf)) | Her salary at St. Joseph's was $220,245.42 in 2019 and $252,330.60 in 2021.((//Public Salary Disclosure - St. Joseph’s Care Group - 2019.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20210325162058/https://www.sjcg.net/documents/accountability/salary-executive-contracts/salary/2019_Public-Sector-Salary-Disclosure_Bilingual.pdf)) ((//Public Salary Disclosure - St. Joseph’s Care Group 2021.// St. Joseph’s Care Group. Retrieved May 1, 2022, from https://web.archive.org/web/20220502014258/https://sjcg.net/documents/accountability/salary-executive-contracts/salary/2021_Public_Sector_Salary_Disclosure_Bilingual.pdf)) |
| | |
| | She formerly worked as the medical director of the [[First Place Clinic and Regional Resource Centre]] under the [[Canadian Mental Health Association]].((//First Place Clinic and Regional Resource Centre.// (2016, November 4). Canadian Mental Health Association - Thunder Bay. https://archive.ph/VDr19)) |
| | |
| | ==== NorthBEAT ==== |
| | |
| | In 2012, Cheng was awarded a 3-year New Investigator Research Award from the [[SickKids Foundation]] and [[Canadian Institutes of Health Research]] (CIHR) for The [[NorthBEAT]] Project. |
| | |
| | ==== SickKids Foundation ==== |
| | |
| | In 2017, Cheng served as a member of the New Investigator Program Grant Review Committee for the [[SickKids Foundation]].((//New Investigator Program Grant Review Committee September 2017.// (2017, September). Wayback Machine; SickKids Foundation. https://web.archive.org/web/20220502035214/https://www.sickkidsfoundation.com/-/media/files/skf/downloadable-resources/pdfs/about-us/grants/grc-members-list-2017.pdf)) |
| | |
| ==== Ontario COVID-19 Science Advisory Table ==== | ==== Ontario COVID-19 Science Advisory Table ==== |
| |
| Cheng is a member of the Mental Health Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/)) | Cheng is a member of the Mental Health Working Group of the [[Ontario COVID-19 Science Advisory Table]].((//About Us.// Ontario COVID-19 Science Advisory Table. Retrieved April 28, 2022, from https://covid19-sciencetable.ca/about/)) |
| | |
| | ===== Research ===== |
| | |
| | ==== Awards and funding ==== |
| | |
| | In February 2020, Cheng received the PSI-50 Mid-Career Clinical Research Award from the [[PSI Foundation]].((//PSI-50 Mid-Career Clinical Research Award - Dr. Chiachen Cheng.// (2020, February 18). PSI Foundation. https://www.psifoundation.org/psi-50-mid-career-clinical-research-award-dr-chiachen-cheng/)) |
| | |
| | Cheng has co-authored research funded by the [[Canadian Pharmaceutical Association]] (CPhA, now the [[Canadian Pharmacists Association]]) and the [[Canadian Medical Association]] (CMA).((//Meta-analysis of benzodiazepine use in the treatment of insomnia.// |
| | Anne M. Holbrook, Renée Crowther, Ann Lotter, Chiachen Cheng, Derek King |
| | CMAJ Jan 2000, 162 (2) 225-233)) |